Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Statistical | 4 | 2021 | 448 | 1.440 |
Why?
|
| Diabetes Mellitus, Type 1 | 7 | 2020 | 529 | 1.270 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 767 | 0.900 |
Why?
|
| Patient Dropouts | 1 | 2021 | 98 | 0.750 |
Why?
|
| Kallikreins | 1 | 2020 | 323 | 0.660 |
Why?
|
| Awareness | 1 | 2019 | 81 | 0.650 |
Why?
|
| Diabetic Angiopathies | 3 | 2015 | 203 | 0.610 |
Why?
|
| Vaping | 1 | 2020 | 124 | 0.610 |
Why?
|
| Longitudinal Studies | 5 | 2021 | 1054 | 0.550 |
Why?
|
| Prekallikrein | 1 | 2015 | 66 | 0.520 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2015 | 54 | 0.520 |
Why?
|
| Kidney Transplantation | 3 | 2015 | 839 | 0.510 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 114 | 0.500 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 454 | 0.470 |
Why?
|
| Kidney | 2 | 2017 | 945 | 0.470 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 561 | 0.460 |
Why?
|
| Lebanon | 5 | 2020 | 67 | 0.450 |
Why?
|
| Mass Screening | 1 | 2019 | 843 | 0.440 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 940 | 0.430 |
Why?
|
| Connective Tissue Growth Factor | 4 | 2018 | 76 | 0.410 |
Why?
|
| Poisson Distribution | 1 | 2011 | 85 | 0.390 |
Why?
|
| Computer Simulation | 3 | 2021 | 706 | 0.370 |
Why?
|
| Risk Factors | 7 | 2022 | 5731 | 0.310 |
Why?
|
| Likelihood Functions | 2 | 2021 | 106 | 0.290 |
Why?
|
| Young Adult | 7 | 2021 | 5717 | 0.280 |
Why?
|
| Humans | 21 | 2022 | 68618 | 0.270 |
Why?
|
| Receptor, Bradykinin B2 | 2 | 2019 | 75 | 0.270 |
Why?
|
| Male | 16 | 2021 | 37321 | 0.260 |
Why?
|
| Female | 15 | 2021 | 38074 | 0.250 |
Why?
|
| Diabetic Nephropathies | 4 | 2012 | 161 | 0.240 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 1046 | 0.230 |
Why?
|
| Adult | 10 | 2021 | 21403 | 0.230 |
Why?
|
| Linear Models | 2 | 2015 | 521 | 0.230 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2019 | 317 | 0.220 |
Why?
|
| Anesthesia, Conduction | 1 | 2022 | 14 | 0.210 |
Why?
|
| Ventricular Premature Complexes | 1 | 2021 | 10 | 0.200 |
Why?
|
| Middle Aged | 10 | 2021 | 21147 | 0.200 |
Why?
|
| Thermography | 1 | 2021 | 20 | 0.190 |
Why?
|
| beta-Thalassemia | 1 | 2021 | 17 | 0.190 |
Why?
|
| Diabetic Foot | 1 | 2021 | 33 | 0.190 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 2800 | 0.190 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2022 | 134 | 0.190 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2022 | 186 | 0.190 |
Why?
|
| Vascular Diseases | 1 | 2021 | 94 | 0.190 |
Why?
|
| Cohort Studies | 5 | 2020 | 2358 | 0.180 |
Why?
|
| Exercise Test | 1 | 2021 | 242 | 0.180 |
Why?
|
| Oral Health | 1 | 2020 | 49 | 0.180 |
Why?
|
| Aorta | 2 | 2019 | 316 | 0.170 |
Why?
|
| Heart Rate | 1 | 2021 | 568 | 0.170 |
Why?
|
| Urbanization | 1 | 2019 | 4 | 0.170 |
Why?
|
| Protein Interaction Maps | 1 | 2019 | 30 | 0.170 |
Why?
|
| Adolescent | 5 | 2022 | 8912 | 0.170 |
Why?
|
| Receptors, Thromboxane | 1 | 2019 | 122 | 0.160 |
Why?
|
| Social Class | 1 | 2019 | 127 | 0.160 |
Why?
|
| Endovascular Procedures | 1 | 2022 | 366 | 0.160 |
Why?
|
| Nanoparticles | 1 | 2021 | 254 | 0.160 |
Why?
|
| Educational Status | 1 | 2019 | 273 | 0.150 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 2279 | 0.150 |
Why?
|
| Parents | 1 | 2020 | 312 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2021 | 2007 | 0.150 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 955 | 0.140 |
Why?
|
| Exercise | 1 | 2021 | 658 | 0.130 |
Why?
|
| Proteomics | 1 | 2017 | 246 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2019 | 326 | 0.130 |
Why?
|
| Fibromyalgia | 1 | 2015 | 29 | 0.130 |
Why?
|
| Hepatitis A | 1 | 2014 | 8 | 0.120 |
Why?
|
| Cholesterol | 1 | 2015 | 331 | 0.120 |
Why?
|
| Treatment Outcome | 3 | 2022 | 7029 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 807 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2015 | 867 | 0.100 |
Why?
|
| Normal Distribution | 1 | 2011 | 46 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2015 | 1451 | 0.100 |
Why?
|
| Bias | 1 | 2011 | 148 | 0.090 |
Why?
|
| Blood Urea Nitrogen | 1 | 2010 | 65 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 195 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 498 | 0.090 |
Why?
|
| Epoprostenol | 1 | 2010 | 71 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 1 | 2011 | 329 | 0.090 |
Why?
|
| Hypertension | 1 | 2019 | 1535 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 2010 | 223 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 110 | 0.080 |
Why?
|
| Demography | 1 | 2010 | 279 | 0.080 |
Why?
|
| Aged | 3 | 2020 | 14862 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 138 | 0.080 |
Why?
|
| Bradykinin | 1 | 2010 | 157 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1085 | 0.080 |
Why?
|
| Tissue Donors | 1 | 2010 | 195 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 615 | 0.080 |
Why?
|
| Immediate-Early Proteins | 1 | 2008 | 63 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 627 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 146 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 371 | 0.070 |
Why?
|
| Employment | 2 | 2019 | 154 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2019 | 880 | 0.060 |
Why?
|
| Rats | 3 | 2019 | 5300 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 3259 | 0.060 |
Why?
|
| Prevalence | 2 | 2019 | 1619 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2021 | 3705 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2017 | 631 | 0.050 |
Why?
|
| Inflammation | 1 | 2008 | 1030 | 0.050 |
Why?
|
| Emulsions | 1 | 2021 | 10 | 0.050 |
Why?
|
| Sulfates | 1 | 2021 | 28 | 0.050 |
Why?
|
| North America | 1 | 2021 | 112 | 0.050 |
Why?
|
| Alginates | 1 | 2021 | 35 | 0.050 |
Why?
|
| Blood Circulation | 1 | 2021 | 18 | 0.050 |
Why?
|
| Polyesters | 1 | 2021 | 55 | 0.050 |
Why?
|
| Fingers | 1 | 2021 | 39 | 0.050 |
Why?
|
| Time Factors | 2 | 2022 | 4655 | 0.050 |
Why?
|
| Dental Care | 1 | 2020 | 34 | 0.050 |
Why?
|
| Heparin | 1 | 2021 | 205 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 2083 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2019 | 2673 | 0.040 |
Why?
|
| Wound Healing | 1 | 2021 | 260 | 0.040 |
Why?
|
| Perception | 1 | 2020 | 189 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 2 | 2012 | 274 | 0.040 |
Why?
|
| Sudan | 1 | 2019 | 3 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 55 | 0.040 |
Why?
|
| Survival Rate | 1 | 2021 | 1056 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2019 | 44 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2019 | 71 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2019 | 144 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 247 | 0.040 |
Why?
|
| Carotid Arteries | 2 | 2008 | 110 | 0.040 |
Why?
|
| Animals | 4 | 2019 | 20881 | 0.040 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2017 | 38 | 0.040 |
Why?
|
| Endpoint Determination | 1 | 2018 | 82 | 0.040 |
Why?
|
| Kininogens | 1 | 2017 | 88 | 0.040 |
Why?
|
| Urban Population | 1 | 2019 | 255 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 120 | 0.040 |
Why?
|
| Albuminuria | 2 | 2008 | 171 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 139 | 0.040 |
Why?
|
| Prognosis | 1 | 2021 | 2093 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 282 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 445 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 792 | 0.030 |
Why?
|
| Rural Population | 1 | 2019 | 398 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 284 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 554 | 0.030 |
Why?
|
| Hepatitis A Antibodies | 1 | 2014 | 1 | 0.030 |
Why?
|
| Hepatitis A virus | 1 | 2014 | 4 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2022 | 1615 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2014 | 41 | 0.030 |
Why?
|
| Insulin | 1 | 2017 | 619 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 546 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2017 | 718 | 0.030 |
Why?
|
| Acute Disease | 1 | 2014 | 658 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2012 | 2689 | 0.030 |
Why?
|
| Logistic Models | 1 | 2015 | 1420 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1553 | 0.020 |
Why?
|
| Comorbidity | 1 | 2015 | 1426 | 0.020 |
Why?
|
| Smad1 Protein | 1 | 2010 | 10 | 0.020 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 7277 | 0.020 |
Why?
|
| Veterans | 1 | 2018 | 904 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 42 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2010 | 207 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 159 | 0.020 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2010 | 73 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2010 | 114 | 0.020 |
Why?
|
| Child | 1 | 2020 | 6405 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 150 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 147 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 266 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 536 | 0.020 |
Why?
|
| Tunica Media | 1 | 2008 | 33 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 1015 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2008 | 59 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 710 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 1692 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 786 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 954 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 3187 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 682 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2008 | 180 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2008 | 179 | 0.020 |
Why?
|
| Smoking | 1 | 2015 | 1452 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 786 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 737 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2010 | 1664 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2008 | 483 | 0.020 |
Why?
|
| Biomarkers | 1 | 2008 | 1593 | 0.010 |
Why?
|
| Mice | 1 | 2012 | 8474 | 0.010 |
Why?
|